OverviewChartNewsTraderScreen

Soc. Generale Knock-Out AZN/  DE000SQ4ZQ75  /

EUWAX
03/07/2024  08:25:35 Chg.-0.10 Bid19:03:16 Ask19:03:16 Underlying Strike price Expiration date Option type
1.96EUR -4.85% 1.86
Bid Size: 3,000		 1.88
Ask Size: 3,000		 AstraZeneca PLC 1,193.4701 SEK 31/12/2078 Call
GlobeNewswire 26/06 As the PNH Market Continues to Crowd, Spherix Announces New Suite of Advisory Services to Explore Co...
GlobeNewswire 20/06 Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire 18/06 Mika Health Collaborates with AstraZeneca and Daiichi Sankyo to Deliver AI-Enabled Mobile Support to...
GlobeNewswire 18/06 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 13/06 Rheumatologists' Aggressive Approach to SLE Treatment Targets Specific Patient Types with Biologics
GlobeNewswire 28/05 Cellectis Reports Financial Results for First Quarter 2024
TeleTrader 21/05 AstraZeneca to deliver $80B total revenue by 2030
TeleTrader 20/05 AstraZeneca to build $1.5B plant in Singapore
GlobeNewswire 08/05 Annual NMDP Gala in New York Raises More Than $560,000, Enabling More Patients to Receive Life-Savin...
GlobeNewswire 08/05 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...
GlobeNewswire 06/05 FibroGen Reports First Quarter 2024 Financial Results
GlobeNewswire 06/05 Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire 29/04 Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
TeleTrader 25/04 Europe opens mostly down after corporate earnings
TeleTrader 25/04 AstraZeneca Q1 revenue jumps 19% to $12.7B
GlobeNewswire 01/04 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: AdTheorent ...
GlobeNewswire 28/03 HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire 19/03 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Fusion Phar...
TeleTrader 19/03 AstraZeneca to acquire Fusion for $2 billion
GlobeNewswire 18/03 AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
TeleTrader 14/03 AstraZeneca to acquire Amolyt Pharma for $1.05B
GlobeNewswire 14/03 Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
GlobeNewswire 28/02 HUTCHMED Reports 2023 Full Year Results and Provides Business Updates
GlobeNewswire 26/02 FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 26/02 FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...